𝔖 Bobbio Scriptorium
✦   LIBER   ✦

S11.2: Breast Cancer in Saarland 1980-2000 - trends and determinants in survival

✍ Scribed by Christa Stegmaier; Irene Schmidtmann

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
75 KB
Volume
46
Category
Article
ISSN
0323-3847

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Is breast cancer survival improving? : T
Is breast cancer survival improving? : Trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000
✍ Sharon H. Giordano; Aman U. Buzdar; Terry L. Smith; Shu-Wan Kau; Ying Yang; Gabr πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 113 KB

## Abstract ## BACKGROUND Despite advances in therapies for breast cancer, improvement in survival for patients with recurrent or metastatic breast cancer has been difficult to establish. The objective of the current study was to determine whether the survival of women with recurrent breast cancer

Time trends of breast cancer survival in
Time trends of breast cancer survival in Europe in relation to incidence and mortality
✍ Milena Sant; Silvia Francisci; Riccardo Capocaccia; Arduino Verdecchia; Claudia πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 265 KB πŸ‘ 2 views

## Abstract Increasing breast cancer survival, observed in most western countries, is not easily interpreted: it could be due to better treatment, more effective treatment due to earlier diagnosis or simply lead‐time bias. Increased diagnostic activity (__e.g.__, screening) can inflate both inciden

Trends in cervical and breast cancer in
Trends in cervical and breast cancer in Iceland. A statistical evaluation of trends in incidence and mortality for the period 1955–1989, their relation to screening and prediction to the year 2000
✍ Kristjan Sigurdsson; Stefan Adalsteinsson; Jonas Ragnarsson πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 681 KB

The time trends in incidence and mortality from cervical cancer and breast cancer in Iceland, from 1955 to 1989, were analyzed by fitting curvilinear regressions to the agestandardized rates. The effect of the screening was evaluated by comparing the curvature of the fitted regression lines and chan

High-resolution genomic analysis of the
High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1
✍ Elin Karlsson; Marie AhnstrΓΆm Waltersson; Josefine Bostner; Gizeh PΓ©rez-Tenorio; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 604 KB

## Abstract The chromosomal region 11q13 is amplified in 15–20% of breast cancers; an event not only associated with estrogen receptor (ER) expression but also implicated in resistance to endocrine therapy. Coamplifications of the 11q13 and 8p12 regions are common, suggesting synergy between the am